Literature DB >> 23867328

Performance of stool cultures before and after a 3-day hospitalization: fewer cultures, better for patients and for money.

Rémi Le Guern1, Caroline Loïez, Bruno Grandbastien, René Courcol, Frédéric Wallet.   

Abstract

We evaluated retrospectively the yield of stool culture (SC) depending on the length of hospitalization, and we characterized the patients missed by the 3-day rejection rule. SC detects bacterial enteric pathogens (Campylobacter spp., Salmonella enterica, Yersinia spp., Shigella spp.). During this 5-year study period, 13,039 SCs were requested, and 376 were positive (2.9%). The yield of SC dropped from 11.7% before 3 days of hospitalization to 0.7% after 3 days in children and 4.3% to 0.3% in adults. Finally, only 13 clinically relevant cases (0.2% of SC prescribed after 3 days) were undiagnosed by strict application of the 3-day rule. In conclusion, rejection of SC prescribed after 3 days of hospitalization allows to reduce workload by 37.8% for children and 65.7% for adults, representing a cost of €12,500 ($16,250) per year in our hospital.
© 2013.

Entities:  

Keywords:  Bacterial diarrhoea; Cost savings; Length of hospitalization; Stool culture

Mesh:

Year:  2013        PMID: 23867328     DOI: 10.1016/j.diagmicrobio.2013.06.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  The "3-Day Rule" for Stool Tests May Not Apply When Using PCR Panels.

Authors:  Stacy G Beal; Lymaries Velez; Elizabeth E Tremblay; Steven Toffel; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool Cultures.

Authors:  Tamar Berger; Odil Giladi; Dafna Yahav; Haim Ben-Zvi; Oren Pasvolsky; Liat Shargian-Alon; Ofir Wolach; Uri Rozovski; Pia Raanani; Moshe Yeshurun
Journal:  Infect Dis Ther       Date:  2021-03-04

3.  Stool cultures at the ICU: get rid of it!

Authors:  Carolin F Manthey; Darja Dranova; Martin Christner; Laura Berneking; Stefan Kluge; Ansgar W Lohse; Valentin Fuhrmann
Journal:  Ann Intensive Care       Date:  2018-01-18       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.